Ferritin in atherosclerosis

Clinica Chimica Acta

Volumn 357, Issue 1, 2005, Pages 1-16

  You, Sun Ah ^a   Wang, Qing ^a  

^a NONE

Author keywords

Atherosclerosis; Coronary artery disease; Ferritin; Iron; Proteomics

Indexed keywords

BIOLOGICAL MARKER; FERRITIN; PROTEIN SUBUNIT;

ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CAUSE OF DEATH; CORONARY ARTERY DISEASE; CYTOKINE PRODUCTION; DEVELOPING COUNTRY; FERRITIN BLOOD LEVEL; GENE FUNCTION; GENE MUTATION; GENE STRUCTURE; HEART INFARCTION; HEMOCHROMATOSIS; HUMAN; HYPERFERRITINEMIA; INCIDENCE; IRON BLOOD LEVEL; IRON METABOLISM; IRON STORAGE; IRON TRANSPORT; MOLECULAR BIOLOGY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEOMICS; REVIEW; STRUCTURE ANALYSIS; TRANSCRIPTION REGULATION;

ARTERIOSCLEROSIS; BIOLOGICAL MARKERS; CERULOPLASMIN; CYTOKINES; FERRITINS; FERROUS COMPOUNDS; HUMANS; MYOCARDIAL INFARCTION; OXIDATIVE STRESS; PROTEIN PROCESSING, POST-TRANSLATIONAL; TRANSCRIPTION, GENETIC;

EID: 20444452107     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2005.02.001     Document Type: Review

References (155)

1. J.L. Sullivan Iron and the sex difference in heart disease risk Lancet 1 1981 1293 1294
2. J.T. Salonen, K. Nyyssonen, H. Korpela, J. Tuomilehto, R. Seppanen, and R. Salonen High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men Circulation 86 1992 803 811
3. J.T. Salonen, K. Nyyssonen, and R. Salonen Body iron stores and the risk of coronary heart disease N Engl J Med 331 1994 1159
4. T.P. Tuomainen, K. Punnonen, K. Nyyssonen, and J.T. Salonen Association between body iron stores and the risk of acute myocardial infarction in men Circulation 97 1998 1461 1466
5. T.P. Tuomainen, U. Diczfalusy, J. Kaikkonen, K. Nyyssonen, and J.T. Salonen Serum ferritin concentration is associated with plasma levels of cholesterol oxidation products in man Free Radic Biol Med 35 2003 922 928
6. H.I. Morrison, R.M. Semenciw, Y. Mao, and D.T. Wigle Serum iron and risk of fatal acute myocardial infarction Epidemiology 5 1994 243 246
7. S. Kiechl, F. Aichner, F. Gerstenbrand, G. Egger, A. Mair, and G. Rungger Body iron stores and presence of carotid atherosclerosis. Results from the Bruneck study Arterioscler Thromb 14 1994 1625 1630
8. S. Kiechl, J. Willeit, G. Egger, W. Poewe, and F. Oberhollenzer Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study Circulation 96 1997 3300 3307
9. C. Moroz, H. Bessler, M. Katz, I. Zahavi, H. Salman, and M. Djaldetti Elevated serum ferritin level in acute myocardial infarction Biomed Pharmacother 51 1997 126 130
10. K. Klipstein-Grobusch, J.F. Koster, D.E. Grobbee, J. Lindemans, H. Boeing, and A. Hofman Serum ferritin and risk of myocardial infarction in the elderly: the Rotterdam study Am J Clin Nutr 69 1999 1231 1236
11. M. Baykan, U. Celik, A. Orem, M. Malkoc, C. Erdol, and E.C. Baykan Iron status and its relationship with lipid peroxidation in patients with acute myocardial infarction Acta Cardiol 56 2001 277 281
12. W.D. Silvia, S. Biswas, S. Uthappa, and P. Shetty Ferritin, a potent threat for acute myocardial infarction? J Assoc Physicians India 51 2003 947 950
13. B. Wolff, H. Volzke, J. Ludemann, D. Robinson, D. Vogelgesang, and A. Staudt association between high serum ferritin levels and carotid atherosclerosis in the study of health in Pomerania (SHIP) Stroke 35 2004 453 457
14. B. Halliwell, and J.M. Gutteridge Protection against oxidants in biological systems: the superoxide theory of oxygen toxicity Free radicals in biology and medicine 1989 Oxford University Press New York (NY) 86 179
15. J.M. McCord Effects of positive iron status at a cellular level Nutr Rev 54 1996 85 88
16. T.P. Ryan, and S.D. Aust The role of iron in oxygen-mediated toxicities Crit Rev Toxicol 22 1992 119 141
17. J.D. Cook, D.A. Lipschitz, L.E. Miles, and C.A. Finch Serum ferritin as a measure of iron stores in normal subjects Am J Clin Nutr 27 1974 681 687
18. A. Takkunen, A. Reunanen, P. Knekt, and A. Aromaa Body iron stores and the risk of cancer (letter) N Engl J Med 320 1989 1013 1014
19. Y.T. van der Schouw, A.L. Verbeek, and J.H. Ruijs ROC curves for the initial assessment of new diagnostic tests Fam Pract 9 1992 506 511
20. M.J. Stampfer, F. Grodatein, I. Rosenberg, W. Willett, and C. Hennekens A prospective study of plasma ferritin and risk of myocardial infarction in US physicians [Abstract] Circulation 87 1993 688
21. W.S. Aronow Serum ferritin is not a risk factor for coronary artery disease in men and women aged > or = 62 years Am J Cardiol 72 1993 347 348
22. A. Ascherio, W.C. Willett, E.B. Rimm, E.L. Giovannucci, and M.J. Stampfer Dietary iron intake and risk of coronary disease among men Circulation 89 1994 969 974
23. M. Manttari, V. Manninen, J.K. Huttunen, T. Palosuo, C. Ehnholm, and O.P. Heinonen Serum ferritin and ceruloplasmin as coronary risk factors Eur Heart J 15 1994 1599 1603
24. M.K. Magnusson, N. Sigfusson, H. Sigvaldason, G.M. Johannesson, S. Magnusson, and G. Thorgeirsson Low iron-binding capacity as a risk factor for myocardial infarction Circulation 89 1994 102 108
25. C.T. Sempos, A.C. Looker, R.F. Gillum, and D.M. Makuc Body iron stores and the risk of coronary heart disease N Engl J Med 330 1994 1119 1124
26. G.H. Frey, and D.W. Krider Serum ferritin and myocardial infarct W V Med J 90 1994 13 15
27. B.C. Solymoss, M. Marcil, B.M. Gilfix, F. Gelinas, A.M. Poitras, and L. Campeau The place of ferritin among risk factors associated with coronary artery disease Coron Artery Dis 5 1994 231 235
28. R. Rauramaa, S. Vaisanen, M. Mercuri, T. Rankinen, I. Penttila, and M.G. Bond Association of risk factors and body iron status to carotid atherosclerosis in middle-aged eastern Finnish men Eur Heart J 15 1994 1020 1027
29. G.G. Duthie, J.A. Beattie, J.R. Arthur, M. Franklin, P.C. Morrice, and W.P. James Blood antioxidants and indices of lipid peroxidation in subjects with angina pectoris Nutrition 10 1994 313 316
30. Y. Liao, R.S. Cooper, and D.L. McGee Iron status and coronary heart disease: negative findings from the NHANES I epidemiologic follow-up study Am J Epidemiol 139 1994 704 712
31. D.M. Baer, I.S. Tekawa, and L.B. Hurley Iron stores are not associated with acute myocardial infarction Circulation 89 1994 2915 2918
32. J. Regnstrom, P. Tornvall, A. Kallner, J. Nilsson, and A. Hamsten Stored iron levels and myocardial infarction at young age Atherosclerosis 106 1994 123 125
33. M. Moore, A.R. Folsom, R.W. Barnes, and J.H. Eckfeldt No association between serum ferritin and asymptomatic carotid atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) study Am J Epidemiol 141 1995 719 723
34. A. Reunanen, H. Takkunen, P. Knekt, R. Seppanen, and A. Aromaa Body iron stores, dietary iron intake and coronary heart disease mortality J Intern Med 238 1995 223 230
35. I.A. van Asperen, E.J. Feskens, C.H. Bowles, and D. Kromhout Body iron stores and mortality due to cancer and ischaemic heart disease: a 17-year follow-up study of elderly men and women Int J Epidemiol 24 1995 665 670
36. V. Hachinski, C. Graffagnino, M. Beaudry, G. Bernier, C. Buck, and A. Donner Lipids and stroke: a paradox resolved Arch Neurol 53 1996 303 308
37. W.S. Aronow, and C. Ahn Three-year follow-up shows no association of serum ferritin levels with incidence of new coronary events in 577 persons aged > or = 62 years Am J Cardiol 78 1996 678 679
38. J.E. Eichner, H. Qi, W.E. Moore, and E. Schechter Iron measures in coronary angiography patients Atherosclerosis 136 1998 241 245
39. A. Enbergs, A. Dorszewski, M. Luft, G. Monnig, A. Kleemann, and H. Schulte Failure to confirm ferritin and caeruloplasmin as risk factors for the angiographic extent of coronary arteriosclerosis Coron Artery Dis 9 1998 119 124
40. W.C. Manfroi, A.J. Zago, P.R. Caramori, R. Cruz, J. Oliveira, and L.S. Kirschnick Does serum ferritin correlate with coronary angiography findings? Int J Cardiol 69 1999 149 153
41. L. Pilote, L. Joseph, P. Belisle, K. Robinson, F. Van Lente, and I.B. Tager Iron stores and coronary artery disease: a clinical application of a method to incorporate measurement error of the exposure in a logistic regression model J Clin Epidemiol 53 2000 809 816
42. C. Bozzini, D. Girelli, E. Tinazzi, O. Olivieri, C. Stranieri, and A. Bassi Biochemical and genetic markers of iron status and the risk of coronary artery disease: an angiography-based study Clin Chem 48 2002 622 628
43. J. Auer, M. Rammer, R. Berent, T. Weber, E. Lassnig, and B. Eber Body iron stores and coronary atherosclerosis assessed by coronary angiography Nutr Metab Cardiovasc Dis 12 2002 285 290
44. M.W. Knuiman, M.L. Divitini, J.K. Olynyk, D.J. Cullen, and H.C. Bartholomew Serum ferritin and cardiovascular disease: a 17-year follow-up study in Busselton, western Australia Am J Epidemiol 158 2003 144 149
45. F. Costanzo, M. Colombo, S. Staempfli, C. Santoro, M. Marone, and R. Frank Structure of gene and pseudogenes of human apoferritin H Nucleic Acids Res 14 1986 721 736
46. C. Santoro, M. Marone, M. Ferrone, F. Costanzo, M. Colombo, and C. Minganti Cloning of the gene coding for human L apoferritin Nucleic Acids Res 14 1986 2863 2876
47. S.K. Jain, K.J. Barrett, D. Boyd, M.F. Favreau, J. Crampton, and J.W. Drysdale Ferritin H and L chains are derived from different multigene families J Biol Chem 260 1985 11762 11768
48. R.V. Lebo, Y.W. Kan, M.C. Cheung, S.K. Jain, and J. Drysdale Human ferritin light chain gene sequences mapped to several sorted chromosomes Hum Genet 71 1985 325 328
49. S.J. Cragg, J. Drysdale, and M. Worwood Genes for the 'H' subunit of human ferritin are present on a number of human chromosomes Hum Genet 71 1985 108 112
50. M. Worwood, J.D. Brook, S.J. Cragg, B. Hellkuhl, B.M. Jones, and P. Perera Assignment of human ferritin genes to chromosomes 11 and 19q13.3-19qter Hum Genet 69 1985 371 374
51. J.H. Caskey, C. Jones, Y.E. Miller, and P.A. Seligman Human ferritin gene is assigned to chromosome 19 Proc Natl Acad Sci U S A 80 1983 482 486
52. S. Levi, B. Corsi, M. Bosisio, R. Invernizzi, A. Volz, and D. Sanford A human mitochondrial ferritin encoded by an intronless gene J Biol Chem 276 2001 24437 24440
53. P.M. Harrison, and P. Arosio The ferritins: molecular properties, iron storage function and cellular regulation Biochim Biophys Acta 1275 1996 161 203
54. E.C. Theil Ferritin: structure, gene regulation, and cellular function in animals, plants, and microorganisms Annu Rev Biochem 56 1987 289 315
55. P. Arosio, T.G. Adelman, and J.W. Drysdale On ferritin heterogeneity. Further evidence for heteropolymers J Biol Chem 253 1978 4451 4458
56. P. Rucker, F.M. Torti, and S.V. Torti Role of H and L subunits in mouse ferritin J Biol Chem 271 1996 33352 33357
57. P. Arosio, M. Yokota, and J.W. Drysdale Structural and immunological relationships of isoferritins in normal and malignant cells Cancer Res 36 1976 1735 1739
58. A. Bomford, C. Conlon-Hollingshead, and H.N. Munro Adaptive responses of rat tissue isoferritins to iron administration. Changes in subunit synthesis, isoferritin abundance, and capacity for iron storage J Biol Chem 256 1981 948 955
59. G. Cairo, L. Bardella, L. Schiaffonati, P. Arosio, S. Levi, and A. Bernelli-Zazzera Multiple mechanisms of iron-induced ferritin synthesis in HeLa cells Biochem Biophys Res Commun 133 1985 314 321
60. Y. Kohgo, M. Yokota, and J.W. Drysdale Differential turnover of rat liver isoferritins J Biol Chem 255 1980 5195 5200
61. M.W. Hentze, T.A. Rouault, S.W. Caughman, A. Dancis, J.B. Harford, and R.D. Klausner A cis-acting element is necessary and sufficient for translational regulation of human ferritin expression in response to iron Proc Natl Acad Sci U S A 84 1987 6730 6734
62. W.E. Walden, S. Daniels-McQueen, P.H. Brown, L. Gaffield, D.A. Russell, and D. Bielser Translational repression in eukaryotes: partial purification and characterization of a repressor of ferritin mRNA translation Proc Natl Acad Sci U S A 85 1988 9503 9507
63. J.L. Casey, M.W. Hentze, D.M. Koeller, S.W. Caughman, T.A. Rouault, and R.D. Klausner Iron-responsive elements: regulatory RNA sequences that control mRNA levels and translation Science 240 1988 924 928
64. E.A. Leibold, and H.N. Munro Cytoplasmic protein binds in vitro to a highly conserved sequence in the 5′ untranslated region of ferritin heavy- and light-subunit mRNAs Proc Natl Acad Sci U S A 85 1988 2171 2175
65. E.C. Theil The ferritin family of iron storage proteins Adv Enzymol Relat Areas Mol Biol 63 1990 421 449
66. N.K. Gray, S. Quick, B. Goossen, A. Constable, H. Hirling, and L.C. Kuhn Recombinant iron-regulatory factor functions as an iron-responsive-element- binding protein, a translational repressor and an aconitase. A functional assay for translational repression and direct demonstration of the iron switch Eur J Biochem 218 1993 657 667
67. D.P. Mascotti, L.S. Goessling, D. Rup, and R.E. Thach Effects of the ferritin open reading frame on translational induction by iron Prog Nucleic Acid Res Mol Biol 55 1996 121 134
68. F. Samaniego, J. Chin, K. Iwai, T.A. Rouault, and R.D. Klausner Molecular characterization of a second iron-responsive element binding protein, iron regulatory protein: 2. Structure, function, and post-translational regulation J Biol Chem 269 1994 30904 30910
69. M.C. Kennedy, L. Mende-Mueller, G.A. Blondin, and H. Beinert Purification and characterization of cytosolic aconitase from beef liver and its relationship to the iron-responsive element binding protein Proc Natl Acad Sci U S A 89 1992 11730 11734
70. J.B. Harford, and R.D. Klausner Coordinate post-transcriptional regulation of ferritin and transferrin receptor expression: the role of regulated RNA-protein interaction Enzyme 44 1990 28 41
71. K. Iwai, S.K. Drake, N.B. Wehr, A.M. Weissman, T. LaVaute, and N. Minato Iron-dependent oxidation, ubiquitination, and degradation of iron regulatory protein: 2. Implications for degradation of oxidized proteins Proc Natl Acad Sci U S A 95 1998 4924 4928
72. M.W. Hentze, and L.C. Kuhn Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric oxide, and oxidative stress Proc Natl Acad Sci U S A 93 1996 8175 8182
73. B.R. Henderson Iron regulatory proteins 1 and 2 Bioessays 18 1996 739 746
74. K.L. Schalinske, K.P. Blemings, D.W. Steffen, O.S. Chen, and R.S. Eisenstein Iron regulatory protein 1 is not required for the modulation of ferritin and transferrin receptor expression by iron in a murine pro-B lymphocyte cell line Proc Natl Acad Sci U S A 94 1997 10681 10686
75. E.G. Meyron-Holtz, M.C. Ghosh, K. Iwai, T. LaVaute, X. Brazzolotto, and U.V. Berger Genetic ablations of iron regulatory proteins 1 and 2 reveal why iron regulatory protein 2 dominates iron homeostasis EMBO J 23 2004 386 395
76. T. LaVaute, S. Smith, S. Cooperman, K. Iwai, W. Land, and E. Meyron-Holtz Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice Nat Genet 27 2001 209 214
77. K.L. Schalinske, and R.S. Eisenstein Phosphorylation and activation of both iron regulatory proteins 1 and 2 in HL-60 cells J Biol Chem 271 1996 7168 7176
78. S.V. Torti, E.L. Kwak, S.C. Miller, L.L. Miller, G.M. Ringold, and K.B. Myambo The molecular cloning and characterization of murine ferritin heavy chain, a tumor necrosis factor-inducible gene J Biol Chem 263 1988 12638 12644
79. Y. Tsuji, L.L. Miller, S.C. Miller, S.V. Torti, and F.M. Torti Tumor necrosis factor-alpha and interleukin 1-alpha regulate transferrin receptor in human diploid fibroblasts. Relationship to the induction of ferritin heavy chain J Biol Chem 266 1991 7257 7261
80. Y. Wei, S.C. Miller, Y. Tsuji, S.V. Torti, and F.M. Torti Interleukin 1 induces ferritin heavy chain in human muscle cells Biochem Biophys Res Commun 169 1990 289 296
81. M. Fahmy, and S.P. Young Modulation of iron metabolism in monocyte cell line U937 by inflammatory cytokines: changes in transferrin uptake, iron handling and ferritin mRNA Biochem J 296 1993 175 181
82. I.M. Smirnov, K. Bailey, C.H. Flowers, N.W. Garrigues, and L.J. Wesselius Effects of TNF-alpha and IL-1beta on iron metabolism by A549 cells and influence on cytotoxicity Am J Physiol 277 1999 L257 L263
83. J. Muntane-Relat, J.C. Ourlin, J. Domergue, and P. Maurel Differential effects of cytokines on the inducible expression of CYP1A1, CYP1A2, and CYP3A4 in human hepatocytes in primary culture Hepatology 22 1995 1143 1153
84. T.N. Tran, S.K. Eubanks, K.J. Schaffer, C.Y. Zhou, and M.C. Linder Secretion of ferritin by rat hepatoma cells and its regulation by inflammatory cytokines and iron Blood 90 1997 4979 4986
85. M. Hirayama, Y. Kohgo, H. Kondo, N. Shintani, K. Fujikawa, and K. Sasaki Regulation of iron metabolism in HepG2 cells: a possible role for cytokines in the hepatic deposition of iron Hepatology 18 1993 874 880
86. J.T. Rogers, K.R. Bridges, G.P. Durmowicz, J. Glass, P.E. Auron, and H.N. Munro Translational control during the acute phase response. Ferritin synthesis in response to interleukin-1 J Biol Chem 265 1990 14572 14578
87. D.J. Pinero, J. Hu, B.M. Cook, R.C. Scaduto Jr., and J.R. Connor Interleukin-1beta increases binding of the iron regulatory protein and the synthesis of ferritin by increasing the labile iron pool Biochim Biophys Acta 1497 2000 279 288
88. Y. Tsuji, H. Ayaki, S.P. Whitman, C.S. Morrow, S.V. Torti, and F.M. Torti Coordinate transcriptional and translational regulation of ferritin in response to oxidative stress Mol Cell Biol 20 2000 5818 5827
89. G. Cairo, L. Tacchini, G. Pogliaghi, E. Anzon, A. Tomasi, and A. Bernelli-Zazzera Induction of ferritin synthesis by oxidative stress. Transcriptional and post-transcriptional regulation by expansion of the "free" iron pool J Biol Chem 270 1995 700 703
90. G. Cairo, E. Castrusini, G. Minotti, and A. Bernelli-Zazzera Superoxide and hydrogen peroxide-dependent inhibition of iron regulatory protein activity: a protective stratagem against oxidative injury FASEB J 10 1996 1326 1335
91. K. Pantopoulos, and M.W. Hentze Activation of iron regulatory protein-1 by oxidative stress in vitro Proc Natl Acad Sci U S A 95 1998 10559 10563
92. K. Pantopoulos, and M.W. Hentze Rapid responses to oxidative stress mediated by iron regulatory protein EMBO J 14 1995 2917 2924
93. F.M. Torti, and S.V. Torti Regulation of ferritin genes and protein Blood 99 2002 3505 3516
94. G. Balla, H.S. Jacob, J. Balla, M. Rosenberg, K. Nath, and F. Apple Ferritin: a cytoprotective antioxidant strategem of endothelium J Biol Chem 267 1992 18148 18153
95. V. Picard, S. Epsztejn, P. Santambrogio, Z.I. Cabantchik, and C. Beaumont Role of ferritin in the control of the labile iron pool in murine erythroleukemia cells J Biol Chem 273 1998 15382 15386
96. D.W. Reif Ferritin as a source of iron for oxidative damage Free Radic Biol Med 12 1992 417 427
97. I. Sakaida, M.E. Kyle, and J.L. Farber Autophagic degradation of protein generates a pool of ferric iron required for the killing of cultured hepatocytes by an oxidative stress Mol Pharmacol 37 1990 435 442
98. R. Ross The pathogenesis of atherosclerosis: a perspective for the 1990s Nature 362 1993 801 809
99. R. Ross The pathogenesis of atherosclerosis-an update N Engl J Med 314 1986 488 500
100. P. Libby, P.M. Ridker, and A. Maseri Inflammation and atherosclerosis Circulation 105 2002 1135 1143
101. S.D. Cushing, J.A. Berliner, A.J. Valente, M.C. Territo, M. Navab, and F. Parhami Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells Proc Natl Acad Sci U S A 87 1990 5134 5138
102. T.B. Rajavashisth, A. Andalibi, M.C. Territo, J.A. Berliner, M. Navab, and A.M. Fogelman Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins Nature 344 1990 254 257
103. Z.M. Dong, S.M. Chapman, A.A. Brown, P.S. Frenette, R.O. Hynes, and D.D. Wagner The combined role of P- and E-selectins in atherosclerosis J Clin Invest 102 1998 145 152
104. R.G. Collins, R. Velji, N.V. Guevara, M.J. Hicks, L. Chan, and A.L. Beaudet P-Selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice J Exp Med 191 2000 189 194
105. J.H. Qiao, J. Tripathi, N.K. Mishra, Y. Cai, S. Tripathi, and X.P. Wang Role of colony-stimulating factor in atherosclerosis: studies of osteopetrotic mice Am J Pathol 150 1997 1687 1699
106. G.T. Gerhard, and P.B. Duell Homocysteine and atherosclerosis Curr Opin Lipidol 10 1999 417 428
107. P. Libby Current concepts of the pathogenesis of the acute coronary syndromes Circulation 104 2001 365 372
108. U. Schonbeck, G.K. Sukhova, K. Shimizu, F. Mach, and P. Libby Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice Proc Natl Acad Sci U S A 97 2000 7458 7463
109. P. Libby Changing concepts of atherogenesis J Intern Med 247 2000 349 358
110. C. Beaumont, P. Leneuve, I. Devaux, J.Y. Scoazec, M. Berthier, and M.N. Loiseau Mutation in the iron responsive element of the L ferritin mRNA in a family with dominant hyperferritinaemia and cataract Nat Genet 11 1995 444 446
111. A.R. Curtis, C. Fey, C.M. Morris, L.A. Bindoff, P.G. Ince, and P.F. Chinnery Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease Nat Genet 28 2001 350 354
112. J. Kato, K. Fujikawa, M. Kanda, N. Fukuda, K. Sasaki, and T. Takayama A mutation, in the iron-responsive element of H ferritin mRNA, causing autosomal dominant iron overload Am J Hum Genet 69 2001 191 197
113. D.L. Witte, W.H. Crosby, C.Q. Edwards, V.F. Fairbanks, and F.A. Mitros Practice guideline development task force of the College of American Pathologists. Hereditary hemochromatosis Clin Chim Acta 245 1996 139 200
114. J.N. Feder, A. Gnirke, W. Thomas, Z. Tsuchihashi, D.A. Ruddy, and A. Basava A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis Nat Genet 13 1996 399 408
115. T.P. Tuomainen, K. Kontula, K. Nyyssonen, T.A. Lakka, T. Helio, and J.T. Salonen Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene Cys282Tyr mutation: a prospective cohort study in men in eastern Finland Circulation 100 1999 274 279
116. M. Roest, Y.T. van der Schouw, B. de Valk, J.J. Marx, M.J. Tempelman, and P.G. de Groot Heterozygosity for a hereditary hemochromatosis gene is associated with cardiovascular death in women Circulation 100 1999 1268 1273
117. M.L. Rasmussen, A.R. Folsom, D.J. Catellier, M.Y. Tsai, U. Garg, and J.H. Eckfeldt A prospective study of coronary heart disease and the hemochromatosis gene (HFE) C282Y mutation: the Atherosclerosis Risk in Communities (ARIC) study Atherosclerosis 154 2001 739 746
118. R.F. Franco, M.A. Zago, M.D. Trip, H. ten Cate, A. van den Ende, and M.H. Prins Prevalence of hereditary haemochromatosis in premature atherosclerotic vascular disease Br J Haematol 102 1998 1172 1175
119. B.A. Nassar, E.M. Zayed, L.M. Title, B.J. O'Neill, I.R. Bata, and S.A. Kirkland Relation of HFE gene mutations, high iron stores and early onset coronary artery disease Can J Cardiol 14 1998 215 220
120. J.M. Annichino-Bizzacchi, S.T. Saad, V.R. Arruda, J.A. Ramires, L.H. Siqueira, and L.C. Chiaparini C282Y mutation in the HLA-H gene is not a risk factor for patients with myocardial infarction J Cardiovasc Risk 7 2000 37 40
121. E. Rossi, B.M. McQuillan, J. Hung, P.L. Thompson, C. Kuek, and J.P. Beilby Serum ferritin and C282Y mutation of the hemochromatosis gene as predictors of asymptomatic carotid atherosclerosis in a community population Stroke 31 2000 3015 3020
122. E. Battiloro, D. Ombres, E. Pascale, E. D'Ambrosio, R. Verna, and M. Arca Haemochromatosis gene mutations and risk of coronary artery disease Eur J Hum Genet 8 2000 389 392
123. R.T. Calado, R.F. Franco, A. Pazin-Filho, M.V. Simoes, J.A. Marin-Neto, and M.A. Zago HFE gene mutations in coronary atherothrombotic disease Braz J Med Biol Res 33 2000 301 306
124. G. Hetet, A. Elbaz, J. Gariepy, V. Nicaud, D. Arveiler, and C. Morrison Association studies between haemochromatosis gene mutations and the risk of cardiovascular diseases Eur J Clin Invest 31 2001 382 388
125. D. Claeys, M. Walting, F. Julmy, W.A. Wuillemin, and B.J. Meyer Haemochromatosis mutations and ferritin in myocardial infarction: a case-control study Eur J Clin Invest 32 Suppl 1 2002 3 8
126. A.M. van der Kraaij, L.J. Mostert, H.G. van Eijk, and J.F. Koster Iron-load increases the susceptibility of rat hearts to oxygen reperfusion damage. Protection by the antioxidant (+)-cyanidanol-3 and deferoxamine Circulation 78 1988 442 449
127. A. Voogd, W. Sluiter, H.G. van Eijk, and J.F. Koster Low molecular weight iron and the oxygen paradox in isolated rat hearts J Clin Invest 90 1992 2050 2055
128. J.A. Araujo, E.L. Romano, B.E. Brito, V. Parthe, M. Romano, and M. Bracho Iron overload augments the development of atherosclerotic lesions in rabbits Arterioscler Thromb Vasc Biol 15 1995 1172 1180
129. T.S. Lee, M.S. Shiao, C.C. Pan, and L.Y. Chau Iron-deficient diet reduces atherosclerotic lesions in apoE-deficient mice Circulation 99 1999 1222 1229
130. B.J. van Lenten, J. Prieve, M. Navab, S. Hama, A.J. Lusis, and A.M. Fogelman Lipid-induced changes in intracellular iron homeostasis in vitro and in vivo J Clin Invest 95 1995 2104 2110
131. A.J. Matthews, G.M. Vercellotti, H.J. Menchaca, P.H. Bloch, V.N. Michalek, and P.H. Marker Iron and atherosclerosis: inhibition by the iron chelator deferiprone (L1) J Surg Res 73 1997 35 40
132. A.M. van der Kraaij, H.G. van Eijk, and J.F. Koster Prevention of postischemic cardiac injury by he orally active iron chelator 1,2-dimethyl-3-hydroxy-4-pyridone (L1) and the antioxidant (+)-cyanidanol-3 Circulation 80 1989 158 164
133. R.E. Williams, J.L. Zweier, and J.T. Flaherty Treatment with deferoxamine during ischemia improves functional and metabolic recovery and reduces reperfusion-induced oxygen radical generation in rabbit hearts Circulation 83 1991 1006 1014
134. A. Patt, I.R. Horesh, E.M. Berger, A.H. Harken, and J.E. Repine Iron depletion or chelation reduces ischemia/reperfusion-induced edema in gerbil brains J Pediatr Surg 25 1990 224 227
135. G.H. Beaton, P.N. Corey, and C. Steele Conceptual and methodological issues regarding the epidemiology of iron deficiency and their implications for studies of the functional consequences of iron deficiency Am J Clin Nutr 50 1989 575 588 [Suppl]
136. J.D. Cook, C.A. Finch, and N.J. Smith Evaluation of the iron status of a population Blood 48 1976 449 455
137. P.L. Fox The copper-iron chronicles: the story of an intimate relationship Biometals 16 2003 9 40
138. M. Arredondo, V. Cambiazo, L. Tapia, M. Gonzalez-Aguero, M.T. Nunez, and R. Uauy Copper overload affects copper and iron metabolism in Hep-G2 cells Am J Physiol Gastrointest Liver Physiol 287 2004 G27 G32
139. J.M. Gutteridge, and J. Stocks Caeruloplasmin: physiological and pathological perspectives Crit Rev Clin Lab Sci 14 1981 257 329
140. J.E. Heffner, and J.E. Repine Pulmonary strategies of antioxidant defense Am Rev Respir Dis 140 1989 531 554
141. F.S. Facchini, and K.L. Saylor Effect of iron depletion on cardiovascular risk factors: studies in carbohydrate-intolerant patients Ann N Y Acad Sci 967 2002 342 351
142. J.T. Salonen, H. Korpela, K. Nyyssonen, E. Porkkala, T.P. Tuomainen, and J.D. Belcher Lowering of body iron stores by blood letting and oxidation resistance of serum lipoproteins: a randomized cross-over trial in male smokers J Intern Med 237 1995 161 168
143. H. van Jaarsveld, and G.F. Pool Beneficial effects of blood donation on high density lipoprotein concentration and the oxidative potential of low density lipoprotein Atherosclerosis 161 2002 395 402
144. C.A. Finch, J.D. Cook, R.F. Labbe, and M. Culala Effect of blood donation on iron stores as evaluated by serum ferritin Blood 50 1977 441 447
145. T.P. Tuomainen, R. Salonen, K. Nyyssonen, and J.T. Salonen Cohort study of relation between donating blood and risk of myocardial infarction in 2682 men in eastern Finland BMJ 314 1997 793 794
146. D.G. Meyers, D. Strickland, P.A. Maloley, J.K. Seburg, J.E. Wilson, and B.F. McManus Possible association of a reduction in cardiovascular events with blood donation Heart 78 1997 188 193
147. J.T. Salonen, T.P. Tuomainen, R. Salonen, T.A. Lakka, and K. Nyyssonen Donation of blood is associated with reduced risk of myocardial infarction. The Kuopio Ischaemic Heart Disease Risk Factor Study Am J Epidemiol 148 1998 445 451
148. C. Smith, M.J. Mitchinson, O.I. Aruoma, and B. Halliwell Stimulation of lipid peroxidation and hydroxyl-radical generation by the contents of human atherosclerotic lesions Biochem J 286 1992 901 905
149. P.S. Thong, M. Selley, and F. Watt Elemental changes in atherosclerotic lesions using nuclear microscopy Cell Mol Biol (Noisy-le-grand) 42 1996 103 110
150. M. Vlad, E. Caseanu, G. Uza, and M. Petrescu Concentration of copper, zinc, chromium, iron and nickel in the abdominal aorta of patients deceased with coronary heart disease J Trace Elem Electrolytes Health Dis 8 1994 111 114
151. J. Swain, and J.M. Gutteridge Prooxidant iron and copper, with ferroxidase and xanthine oxidase activities in human atherosclerotic material FEBS Lett 368 1995 513 515
152. J.H. Pang, M.J. Jiang, Y.L. Chen, F.W. Wang, D.L. Wang, and S.H. Chu Increased ferritin gene expression in atherosclerotic lesions J Clin Invest 97 1996 2204 2212
153. F.Y. Lee, T.S. Lee, C.C. Pan, A.L. Huang, and L.Y. Chau Colocalization of iron and ceroid in human atherosclerotic lesions Atherosclerosis 138 1998 281 288
154. X.M. Yuan, W.L. Anders, A.G. Olsson, and U.T. Brunk Iron in human atheroma and LDL oxidation by macrophages following erythrophagocytosis Atherosclerosis 124 1996 61 73
155. S.A. You, S.R. Archacki, G. Angheloiu, C.S. Moravec, S. Rao, and M. Kinter Proteomic approach to coronary atherosclerosis shows ferritin light chain as a significant marker: evidence consistent with iron hypothesis in atherosclerosis Physiol Genomics 13 2003 25 30